How to get CBD oil on prescription in Australia
Accessing cannabidiol (CBD) oil in Australia follows two distinct pathways depending on how much you need and which scheduling category applies. Since February 2021, low-dose CBD oil has been available as a Schedule 3 pharmacist-only medicine — no prescription required, just a pharmacist consultation. Higher daily amounts remain under Schedule 4 and require a doctor’s prescription. Understanding which pathway applies to your situation is the first step.
This article covers both access pathways, what’s involved in each, what to expect from the process and what questions to ask. For the broader legal framework, the CBD oil legality in Australia article covers TGA scheduling in detail. For those who have already decided to buy without a prescription, the CBD without prescription guide and the buying CBD oil online guide cover those pathways.
Schedule 3 — pharmacist-only, no prescription needed
Schedule 3 is the lower-access pathway. Products approved under Schedule 3 are available directly from a pharmacist without a doctor’s prescription. The current Schedule 3 framework for CBD applies to products with a maximum daily dose of 150 mg of cannabidiol for adults aged 18 and over.
To access Schedule 3 CBD oil at a pharmacy:
- Go to a pharmacy that stocks TGA-approved Schedule 3 CBD products
- Speak with the pharmacist — they are required to assess whether the product is appropriate for you before supplying it
- The pharmacist may ask about existing medications, health conditions and what you intend to use the product for
- If the pharmacist is satisfied the product is appropriate, they can supply it without a prescription
Not every pharmacy stocks Schedule 3 CBD products. Availability varies by location and the pharmacy’s purchasing decisions. The Chemist Warehouse CBD oil article covers what’s available through that specific chain. Calling ahead to confirm stock before visiting saves time.
Schedule 3 access is limited to 150 mg per day. If a healthcare professional recommends a daily amount above that threshold, Schedule 4 with a prescription is required.
Schedule 4 — prescription required
Schedule 4 CBD oil requires a prescription from a registered medical practitioner — a GP, specialist or other authorised prescriber. This pathway covers daily CBD amounts above 150 mg and any situation where a doctor determines that a prescription-level product is more appropriate than a Schedule 3 option.
The prescription process follows the same general steps as any other medication:
- Book an appointment with a GP or relevant specialist
- Discuss your situation and whether CBD oil is appropriate for you
- If the doctor decides to prescribe, they issue a standard prescription or access the product through the TGA’s Special Access Scheme (SAS) pathway, depending on whether a TGA-approved product is available for your situation
- Take the prescription to a pharmacy that can compound or dispense the prescribed product
Not all GPs have experience prescribing CBD oil. Some will refer to a specialist — typically a pain specialist, neurologist or psychiatrist depending on the clinical context. Telehealth services specialising in cannabinoid medicines have expanded since 2020 and provide another access route for patients who cannot readily access a local GP with relevant experience.
The Special Access Scheme
Where a patient requires a CBD product that doesn’t hold standard TGA approval for their specific indication, doctors can apply through the TGA’s Special Access Scheme (SAS). The SAS allows practitioners to prescribe unapproved therapeutic goods for individual patients when the clinical circumstances warrant it.
SAS Category B is the most commonly used pathway for cannabinoid medicines — the prescribing doctor applies to the TGA on behalf of a specific patient, providing clinical justification. Approval is not guaranteed, and processing times vary. Some product types have SAS approval streamlined through the Authorised Prescriber scheme, where specific practitioners are pre-approved to prescribe particular cannabinoid products without applying for each patient individually.
In practice, most patients accessing CBD oil through the prescription pathway use products already listed or approved through existing SAS channels rather than navigating the SAS application process from scratch. A doctor experienced with cannabinoid prescribing will know which products are accessible through which pathway for a given clinical situation.
What to bring to the appointment
Arriving at a GP or pharmacist consultation with specific information makes the process more productive.
Your medication list. CBD is metabolised through the cytochrome P450 enzyme pathway. Certain medications processed through the same pathway may interact with CBD — the prescriber or pharmacist needs to know what you’re currently taking to assess for interactions.
A clear description of what you’re looking for. Rather than asking for “CBD oil,” be specific about why you’re interested, what daily amount you’re considering and whether you’ve used CBD products before. The more specific the information, the better the prescriber can assess whether CBD oil is appropriate and which schedule applies.
Product information if you have a preference. If you’ve already researched a specific product — its concentration, spectrum type and certificate of analysis — bringing that information to the appointment lets the prescriber evaluate the specific product rather than a generic category. The quality criteria guide covers what documentation a well-made CBD oil should have.
Questions. See the section below.
Questions to ask at the appointment
Five questions that cover the practical ground for CBD oil access in Australia:
Which schedule applies to my situation? Schedule 3 (pharmacist-only, up to 150 mg/day) or Schedule 4 (prescription required)? The answer depends on the daily amount and clinical context.
Are there any medication interactions I should know about? CBD’s interaction with the P450 enzyme system is clinically relevant for a range of medications. Your prescriber can check the current interaction profile against your medication list.
Which products are you familiar with prescribing? GPs and specialists who regularly prescribe cannabinoid medicines have typically worked with a limited set of products they know well. Understanding what they typically prescribe helps set expectations.
What does the ongoing process look like? Is this a one-off prescription or an ongoing arrangement? What follow-up is expected? How are adjustments to the prescription handled?
What’s the cost? CBD oil on prescription is not subsidised by the PBS (Pharmaceutical Benefits Scheme) as of 2026. The full product cost plus any dispensing or compounding fees apply. The CBD cost on prescription article covers what to expect and how it compares to purchasing OTC or online.
Cost and access considerations
Prescription CBD oil in Australia is not PBS-subsidised, which means patients pay the full cost. Compounded products (CBD formulated to a specific prescription by a compounding pharmacy) typically cost less than commercially manufactured alternatives but involve a different quality assurance framework.
Telehealth consultations for cannabinoid prescribing are available nationwide and cost less per appointment than in-person specialist visits. Some services charge a flat consultation fee; others charge per appointment plus a product markup. Comparing the total cost — consultation plus product — across different access routes is worth doing before committing to a pathway.
For Australians in locations without readily accessible CBD-experienced practitioners, telehealth expands options significantly. Residents in Perth, Darwin, Townsville or Launceston and those in rural areas face the same telehealth access routes as metropolitan patients in Sydney, Melbourne or Brisbane.
For those accessing CBD oil outside the prescription pathway — through online purchase — the buying CBD in Australia guide covers what’s available, and the Stillroot shop stocks the full EU Labs range for direct purchase.
Frequently asked questions
Do I need a prescription to buy CBD oil in Australia?
Not necessarily. Low-dose CBD oil (up to 150 mg per day) is available as a Schedule 3 pharmacist-only product without a prescription. A pharmacist consultation is required at the point of supply. Amounts above 150 mg per day require a Schedule 4 prescription from a doctor. The CBD without prescription guide covers Schedule 3 access in detail.
Can a GP prescribe CBD oil in Australia?
Yes. Any registered medical practitioner can prescribe CBD oil under Schedule 4. GPs, specialists and telehealth practitioners authorised to prescribe cannabinoid medicines can all issue prescriptions. Not all GPs have experience with cannabinoid prescribing — some will refer to a specialist or a telehealth service with specific expertise.
How long does it take to get a CBD prescription in Australia?
A standard GP appointment can result in a same-day prescription if the doctor determines CBD oil is appropriate and a suitable product is available through the standard pharmacy pathway. SAS applications add processing time on the TGA’s end — typically days to weeks depending on the application type and current workload.
Is CBD oil on prescription covered by Medicare or the PBS?
The GP consultation may attract a Medicare rebate if bulk-billed or gap-covered. The CBD product itself is not PBS-subsidised as of 2026, meaning patients pay the full product cost regardless of concession card status. The prescription cost article covers what to expect for the product component of the total cost.
What’s the difference between a compounded CBD product and a commercial one?
A compounded CBD product is mixed by a compounding pharmacy to a specific prescription — custom concentration, volume and formulation. A commercial product is manufactured at scale and typically holds more formal quality documentation (batch-specific third-party COA, GMP manufacturing). Both are available through the prescription pathway. Compounded products are often cheaper per milligram; commercial products offer more standardised batch-to-batch consistency through documented manufacturing controls.
These products have not been evaluated by the TGA. They are not intended to diagnose, treat, cure, or prevent any disease. You must be 18+ to purchase. Please consult a healthcare professional before use.
